Last checked at 8 Feb 2018 16:31
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
Accrol Group Holdings plc(the "Company")
Director's Dealing
Accrol Group Holdings plc (AIM: ACRL), the AIM-listed leading independent tissue converter, is pleased to announce that Dan Wright, Executive Chairman, has purchased 215,168 ordinary shares of 1 pence each ("Ordinary Shares") on 7 and 8 February 2018 at an average price of 36.0 pence per Ordinary Share.
Following this transaction, Dan has an interest in 415,168 Ordinary Shares, representing approximately 0.32 per cent. of the Company's issued Ordinary Share capital.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Dan Wright | ||||
2 | Reason for the notification | |||||
a) | Position/status | Executive Chairman | ||||
b)
| Initial notification /Amendment | Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Accrol Group Holdings plc | ||||
b) | LEI | 213800MC56M5G69RJ226 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.001
ISIN: GB00BZ6VT592 | ||||
b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price | 215,168 36.0p | ||||
e) | Date of the transaction | 7 and 8 February 2018 | ||||
f) | Place of the transaction | London Stock Exchange, AIM | ||||
For further information, please contact: | |
Accrol Group Holdings plc | |
Gareth Jenkins, Chief Executive Officer | +44 (0) 1254 278 844 |
Zeus Capital Limited (Nominated Adviser & Broker) | |
Dan Bate / Andrew Jones | +44 (0) 161 831 1512 |
Dominic King / John Goold | +44 (0) 203 829 5000 |
Belvedere Communications Limited | |
Cat Valentine (cvalentine@belvederepr.com) | +44 (0) 7715 769 078 |
Notes to Editors
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues as well as other tissue products to the UK's largest retailers.
Accrol operates from three sites:
· A manufacturing, storage and distribution facility in Blackburn;
· A facial tissue plant, also in Blackburn; and
· A manufacturing, storage and distribution facility in Leyland.
In addition, the business has a storage and distribution facility in Skelmersdale, Lancashire.